Polycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes offspring Georgios Boutzios, M.D., Sarantis Livadas, Ph.D., Christina Piperi, Ph.D., Nicolaos Vitoratos, Ph.D., Christos Adamopoulos, Ph.D., Dimitrios Hassiakos, M.D., Ph.D., Christos Iavazzo, Ph.D., Evanthia Diamanti-Kandarakis, M.D., Ph.D. Fertility and Sterility Volume 99, Issue 3, Pages 943-950 (March 2013) DOI: 10.1016/j.fertnstert.2012.10.050 Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions
Figure 1 The association of advanced glycation end products (AGEs) in mothers and neonates (r = 0.605, P<.001). Squares denote individuals with gestational diabetes; crosses indicate individuals with polycystic ovary syndrome; and circles denote controls. Fertility and Sterility 2013 99, 943-950DOI: (10.1016/j.fertnstert.2012.10.050) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions
Figure 2 The association of advanced oxidation protein products (AOPPs) in mothers and neonates (r = 0.735, P<.001). Squares denote individuals with gestational diabetes; crosses indicate individuals with polycystic ovary syndrome; and circles denote controls. Fertility and Sterility 2013 99, 943-950DOI: (10.1016/j.fertnstert.2012.10.050) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions